المؤلفون: Sony Sharlet E., Muralinath E., Guruprasad M., Mohan Naidu K., Srinivas Prasad, Jayinder Paul Singh G., Panjan Ghosh P., Kalyan C., Archana Jain

المصدر: Research and Reviews: Journal of Holistic Nursing, 1(1), 16-18, (2024-05-10)

مصطلحات موضوعية: Pericardial diseases, pharmacotherapy, nonsteroidal anti-inflammatory drugs, colchine, corticosteroids, cytokines and inflammatory pathways, cmorbidities, and risk factors, immuno suppressive drugs, infliximab and adalimumab

Relation: https://zenodo.org/communities/nurse; https://doi.org/10.5281/zenodo.11171037; https://doi.org/10.5281/zenodo.13352892; oai:zenodo.org:13352892

الاتاحة: https://doi.org/10.5281/zenodo.13352892

المؤلفون: Simone Parisi, Enrico Fusaro, Richard Borrelli, M. C. Ditto, Rossella Talotta, Marta Priora

مصطلحات موضوعية: medicine.medical_specialty, business.industry, Adalimumab, Biosimilar, Infliximab, switch, Etanercept, Infliximab, Etanercept, Adalimumab, real-life, originator, biosimilar, switch, originator, medicine, real-life, biosimilar, Intensive care medicine, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7651ab966eff13a59afa31772e3a3fd1
https://mts.intechopen.com/articles/show/title/rheumatic-diseases-and-biosimilars-evidence-about-switch-from-originators-to-biosimilars-in-the-real